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Abstract: Cerebral palsy is one of the main causes of disability in childhood. Resistance therapy
shows benefits in increasing strength and gait in these patients, but its impact on motor function is
not yet clear. The objective was to analyze the impact of resistance therapy on the improvement in the
motor function using a review and meta-analysis. A comprehensive literature research was conducted
in Medline (PubMed), Institute for Scientific Information (ISI) Web of Knowledge, and Physiotherapy
Evidence Database (PEDro) in relation to clinical trials in which resistance therapy was used and
motor function was assessed. Twelve controlled clinical trials and three non-controlled clinical trials
(only one intervention arm) studies were identified. In terms of pre–post difference, the overall
intra-group effect was in favor of resistance therapy intervention: standardized mean difference (SMD)
= 0.37, 95% confidence interval (CI) = 0.21 to 0.52, p < 0.001 (random-effects model), with moderate
heterogeneity (I2 = 59.82%). SMDs were also positive by restricting to each of the analyzed scales:
SMD = 0.37, 1.33, 0.10, and 0.36 for Gross Motor Function Measure (GMFM), Lateral Step Up (LSU),
Time Up and Go (TUG), and Mobility Questionnaire (MobQue) scales, respectively. Regarding
the difference between groups, the results showed a high heterogeneity (I2 < 99%), with the mean
difference (MD) also favorable for the GMFM scale: MD = 1.73, 95% CI = 0.81 to 2.64, p < 0.001
(random-effects model). Our results support a positive impact of resistance therapy on motor function.
Further studies should delve into the clinical relevance of these results.
Keywords: Cerebral palsy; resistance therapy; motor skills; child; meta-analysis
1. Introduction
Cerebral palsy (CP) is currently the most common cause of motor disability in the pediatric
population. In the last 40 years, the incidence of CP increased well above 2.0 per 1000 live births in
developed countries [1].
Most children with CP show a significant weakness in spastic musculature compared with the
least affected. In this sense, current evidence suggests that muscle weakness in CP may contribute to
disability to a greater extent than spasticity itself [2].
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In the past, it was feared that the negative effect of increased spasticity associated with resistance
therapy interventions was greater than the positive effect associated with these therapies on muscle
strength, gait, and motor function [3].
However, a systematic review published in 2002 suggested that resistance exercises could increase
muscle strength without increasing spasticity [4], opening up the possibility that this increase in
strength could be simultaneously associated with improvements in gait or motor function.
Several subsequent primary studies led firstly to the publication of a review in 2009 [5], in which
results were found in favor of motor function based on four published primary studies evaluated.
In 2014, in the Park et al. meta-analysis [6], the authors concluded that resistance therapy improves
muscle strength and that this increase would also affect gait parameters, establishing an intervention
protocol of 40–50 min three days per week. Regarding the motor function, the results were inconclusive,
highlighting the need for more specific studies. The latest meta-analysis published according to our
knowledge as a Cochrane review in 2017 [7] did not find a statistically significant increase in the specific
dimension of the motor function determined using the GMFM scale (Gross Motor Function Measure)
based on the seven primary articles found during their search until June 2016 [8–14].
These inconclusive results regarding motor function may be due both to heterogeneity in the
study population, as not all reviews published to date focused on children [4,6,7], and to heterogeneity
in resistance therapy interventions [6,15,16], as electrical stimulation, for example, was included within
these interventions, when it is actually not resistance work, but involuntary muscle enhancement [17].
Finally, the heterogeneity in the quality of the methodologies applied in the primary studies [5–7] may
also explain the differential results.
These inconclusive results support the need for a systematic review and meta-analysis to know
the specific impact of resistance therapy on motor function, taking into account these sources of
heterogeneity. A meta-analysis that synthesizes the quantitative measures found in relation to resistance
therapy in children in a more homogeneous way, and that incorporates a subgroup analysis based on
the quality of the identified studies would be very useful to establish optimal treatment protocols.
Therefore, the objective of this study was to analyze, through a meta-analysis of published primary
studies, the impact of resistance therapy on the parameters of the motor function in children with CP.
2. Materials and Methods
A bibliographic search was conducted to identify epidemiological studies carried out on
school-aged CP patients (≤18 years), written in English or Spanish, in which resistance therapy
was used and which reported at least one determination in motor function, both pre and post
intervention, in order to assess intra-group change and those that reported differences between groups
in this outcome measure. Different international bibliographic databases were consulted: Medline
through PubMed, Institute for Scientific Information (ISI) Web of Knowledge, and Physiotherapy
Evidence Database (PEDro). All relevant primary studies (published and under publication) until
January 2018 were identified, using the following keywords: “strength training” OR “strengthening”
OR “resistance exercise” AND “cerebral palsy”, using free text and without applying any limitation
in the search strategy. We also performed a manual search within the bibliographic references of the
retrieved studies. In total, 631 primary studies were found in the search in Medline, 1034 in ISI Web of
Knowledge, and 130 in PEDro.
Studies using electrostimulation as resistance therapy and populations with diseases other than
CP were excluded. Table 1 shows the inclusion and exclusion criteria applied to the references found,
either by reading the abstracts or, when necessary, by reading the full text of the primary studies.
Figure 1 shows the flowchart used to identify the primary studies to be included in the review, and it
also reports the reasons for exclusion. For the identification of those ongoing studies, we searched
the electronic database of clinical trial registries: Current Controlled Trials, National Health Service,
The National Research Register, and Clinical Trials.
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Figure 1. Flowchart used for the identification of clinical trials and studies with intervention based on
resistance therapy and motor function measured as the outcome variable.
Table 1. Inclusion and exclusion criteria.
Inclusion Criteria
• School-aged patients diagnosed with CP a (≤18 years)
• Design: both controlled (randomized or quasi-randomized) and non-controlled clinical trials
• Intervention based on resistance therapy
• Language: written in English or Spanish
• Information on at least one determination in motor function, both pre and post intervention,
or differences between groups in these outcome measures in the case of controlled studies
Exclusion Criteria
• Adult patients (≥19 years)
• Population with diseases other than CP
• Electrical stimulation as a resistance therapy of choice
a Cerebral palsy.
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The assessment of the presence of the main types of biases and of the overall methodological
quality in each primary study was carried out in a standardized manner using the tool known as the
PEDro Scale [18–20].
Quality assessment followed the recommendations of Chalmers [21] and Santibañez [22] in order
to minimize observer bias; each article was assigned an identification number, eliminating journal
and author data. Each primary study was assessed independently by two reviewers (L.C.-G. and
M.S.-M.). In cases of discrepancy in the evaluation, it was assessed whether the discrepancy affected
the qualitative rate or the quantitative score, resolved by consensus.
Data Analysis
The standardized mean difference (SMD), with its 95% confidence interval (95% CI), was chosen
as a summary measure of the effect to allow us to combine data for the following motor function
scales: Gross Motor Function Measure (GMFM), Lateral Step Up (LSU), Time Up and Go (TUG),
and Mobility Questionnaire (MobQue) used in the meta-analysis. This strategy, which is consistent
with the approach taken in other reviews [7,23], increases the pool of studies, thereby increasing the
power to detect both intra-group and between-group differences in the motor functions.
In a second strategy, as a sensitivity analysis, the results were restricted to studies using the
GMFM scale. In this second approach, the mean difference (MD) on the natural (non-standardized)
scale was used.
To weight intervention effects, a random-effects model versus a fixed-effects model was chosen
after studying the heterogeneity for each outcome. Statistical heterogeneity was assessed through
Cochran’s Q-test and I2 statistic, which describe the percentage of total variation across studies that is
attributable to statistical heterogeneity rather than to chance. I2 values of 25%, 50%, and 75% correspond
to low, moderate, and high between-study statistical heterogeneity. A p-value <0.10 was set as the
cut-off point for statistically significant heterogeneity in the chi-squared test for heterogeneity [24].
We used the DerSimonian and Laird random-effects model with inverse variance to generate SMDs
and MDs [25].
Subgroup analyses were predefined, attending to the study design, duration of therapy, number
of sessions, duration of each session, and type of intervention protocol, depending on the score in the
analysis of methodological quality.
We sought evidence of publication bias using the funnel plot method and Egger’s regression
asymmetry test [26,27]. In addition, Duval and Tweedie’s “trim and fill” approach was used to obtain
the best estimation of the unbiased effect size [28].
The meta-analysis was written following the recommendations of the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) statement [29]. All analyses were conducted
using Comprehensive Meta-Analysis (CMA v2) [30].
3. Results
According to the selection criteria, 15 original articles were found; 12 were randomized controlled
clinical trials [8–10,12–14,31–36], all of them with two parallel branches (arms), and three were
non-controlled clinical trials (only one intervention arm) [37–39]. Table 2 presents the characteristics of
these finally included studies.
Regarding the assessment of the overall methodological quality in each primary study, two of the
studies obtained an “excellent” score (7–8 points out of 10) [32,36], seven studies obtained a “good”
score (between five and six points) [8,12–14,31,34,35], four studies obtained a “fair” score (between three
and four points) [9,10,33,39], and two of them obtained a “poor” score (two points) [37,38] (see Table 3).
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Table 2. Characteristics of included studies.
First Author.
Publication Year Country Study Design Study Population Duration Procedure Main Results Other Results
Aye et al., 2016 [37] Myanmar Non-randomizedcontrolled trial
40 CP a children
(I–II GMFCS b)
Average age:
6 years
6 weeks
3 times/week
45 min/session
Progressive strength training
GMFM c D (p = 0.056):
Pre: 28.4 ± 11.1
Post: 33.2 ± 11.1
GMFM E (p = 0.009):
Pre: 42.4 ± 19.3
Post: 54.9 ± 22.5
Dodd et al., 2003
[8] Australia
Randomized
controlled trial
21 CP children
(I–III GMFCS)
Average age:
13 years
6 weeks
3 times/week
20–30 min/session
Intervention group (n = 11):
Functional strength
training/conventional therapy
Control group (n = 10):
Conventional therapy
GMFM: intervention group
(p = 0.651): Pre: 64.2 ± 27.8
Post: 69 ± 21.4
Control group (p = 0.729):
Pre: 71.7 ± 24.9
Post: 75.3 ± 21.3
Gait speed (cm/s):
Intervention group (p = 0.950):
Pre: 79 ± 38.83
Post: 80 ± 35.33
Control group:
Pre: 82.5 ± 40.83
Post: 84.16 ± 34.66
Engsberg et al.,
2006 [9] USA
Randomized
controlled trial
12 CP children
(I–III GMFCS)
Average age:
9.9 years
12 weeks
3 times/week
Intervention group (n = 9):
Progressive strength training.
Control group (n = 3):
Non-therapy
GMFM: Intervention group
(p = 0.785): Pre: 65.8 ± 30.8
Post: 69.1 ± 28.4
Gait speed (cm/s):
Intervention group (p = 0.743):
Pre: 85.9 ± 31.1
Post: 91 ± 34.6
Control group:
Pre: 80.1 ± 23.4
Post: 78.6 ± 31.3
Cadence (steps/min):
Intervention group (p = 0.813):
Pre: 120.3 ± 36.3
Post: 124.4 ± 37.2
Control group:
Pre: 121.7 ± 17.9
Post: 123.1 ± 12.9
Step length (cm):
Intervention group (p = 0.826):
Pre: 82.6 ± 21
Post: 84.8 ± 21.4
Control group:
Pre: 80.6 ± 14.8
Post: 77.7 ± 25.8
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Publication Year Country Study Design Study Population Duration Procedure Main Results Other Results
Fowler et al., 2010
[31] USA
Randomized
controlled trial
62 CP children
(I–III GMFCS)
Age: 7–18 years
12 weeks
3 times/week
60 min/session
Intervention group (n = 31):
Resistance training on bicycle
Control group (n = 31):
Non-therapy
GMFM: Intervention group
(p = 0.038): Pre: 69.6 ± 2.1
Post: 70.8 ± 2.07
Control group (p = 0.382):
Pre: 68.8 ± 2.12
Post: 69.3 ± 1.97
Gait speed (cm/s):
Intervention group (p = 0.282):
Pre: 111.5 ± 6.67
Post: 113.33 ± 6.2
Control group:
Pre: 97.83 ± 6.05
Post: 103.5 ± 6.26
Jung et al., 2013
[39] South Korea
Non-randomized
controlled trial
6 CP children
(I GMFCS)
Age: 4–10 years
6 weeks
3 times/week
30 min/session
Progressive strength training
GMFM D (p = 0.805):
Pre: 88.5 ± 15
Post: 90.6 ± 14.5
GMFM E (p = 0.859):
Pre: 78 ± 21.9
Post: 80.3 ± 22.9
Gait speed (cm/s) (p = 0.512):
Pre: 81.4 ± 19
Post: 88.7 ± 19.2
Cadence (steps/min) (p = 0.039):
Pre: 117.7 ± 10.7
Post: 129.6 ± 7.1
Step length (cm) (p = 0.607):
Pre: 84 ± 15.9
Post: 88.9 ± 16.9
Lee et al., 2008 [12] Korea Randomizedcontrolled trial
17 CP children
(II–III GMFCS)
Age: 4–12 years
5 weeks
3 times/week
60 min/session
Intervention group (n = 9):
Table of resistance exercises
Control group (n = 8):
Conventional
neurodevelopmental therapy
GMFM: Intervention group
(p = 0.949): Pre: 86.5 ± 13.3
Post: 86.9 ± 13.4
Control group (p = 0.976):
Pre: 85.2 ± 13.4
Post: 85.4 ± 13.5
Gait speed (cm/s):
Intervention group (p = 0.236):
Pre: 54.7 ± 30.7
Post: 74.6 ± 38.7
Control group:
Pre: 69.8 ± 43
Post: 68.2 ± 42.9
Cadence (steps/min):
Intervention group (p = 0.848):
Pre: 106.8 ± 37.1
Post: 109.7 ± 26
Control group:
Pre: 107.9 ± 48.4
Post: 101.1 ± 47.4
Step length (cm):
Intervention group (p = 0.137):
Pre: 62.5 ± 21.8
Post: 80 ± 26.4
Control group:
Pre: 70 ± 32.1
Post: 68.2 ± 42.9
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First Author.
Publication Year Country Study Design Study Population Duration Procedure Main Results Other Results
Lee et al., 2014 [38] Korea Non-randomizedcontrolled trial
13 CP children
(I–II GMFCS)
Age: 6–18 years
8 weeks
2 times/week
30 min/session
Table of resistance exercises
TUG d (p = 0.225):
Pre: 25.17 ± 7.53
Post: 21.79 ± 6.43
Lee et al., 2015 [14] Korea Randomizedcontrolled trial
26 CP children
(I–III GMFCS)
Age: 5–10 years
6 weeks
3 times/week
50 min/session
Intervention group (n = 13):
Functional strength
training/conventional
neurodevelopmental therapy
Control group (n = 13):
Conventional
neurodevelopmental therapy
GMFM: Intervention group
(p = 0.575): Pre: 78 ± 19.1
Post: 81.9 ± 16.1
Control group (p = 0.699):
Pre: 79.1 ± 14.7
Post: 81.3 ± 14.3
MobQue e:
Intervention group (p = 0.318):
Pre: 55.7 ± 29.9
Post: 66.9 ± 26.7
Control group (p = 0.757):
Pre: 48.3 ± 26.9
Post: 51.5 ± 25.7
Liao et al., 2007
[10] China
Randomized
controlled trial
20 CP children
(I–II GMFCS)
Age: 5–12 years
6 weeks
3 times/week
90 min/session
Intervention group (n = 10):
Table of resistance
exercises/conventional
neurodevelopmental therapy
Control group (n = 10):
Conventional
neurodevelopmental therapy
GMFM: Intervention group
(p = 0.596): Pre: 76.6 ± 13.91
Post: 79.8 ± 12.96
Control group (p = 0.925):
Pre: 83.1 ± 10.11
Post: 83.5 ± 8.85
Int. J. Environ. Res. Public Health 2019, 16, 4513 8 of 21
Table 2. Cont.
First Author.
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Pandey et al., 2011
[35] India
Randomized
controlled trial
18 CP children
Age: 5–10 years
4 weeks
2 times/week
60 min/session
Intervention group (n = 9):
Functional strength training
Control group (n = 9):
Non-therapy
Lateral step up
(left): Intervention group
(p < 0.001):
Pre: 6.22 ± 1.44
Post: 11.8 ± 3
Control group (p = 0.522):
Pre: 6.44 ± 1.66
Post: 6 ± 1.2 Lateral step up
(right):
Intervention group (p = 0.000):
Pre: 6.4 ± 1.6
Post: 12.6 ± 2.24 Control group
(p = 0.394):
Pre: 5.8 ± 1.2
Post: 5.34 ± 1.06
Gait speed: Intervention group
(p = 0.001):
Pre: 54 ± 8
Post: 70 ± 10
Control group:
Pre: 59 ± 9
Post: 60 ± 10 Cadence:
Intervention group (p = 0.004):
Pre: 111 ± 10
Post: 127 ± 11
Control group:
Pre: 125 ± 27
Post: 127 ± 26
Step length:
Intervention group (p = 1.000):
Pre: 63 ± 16
Post: 63 ± 10
Control group:
Pre: 58 ± 14
Post: 60 ± 10
Peungsuwan et al.,
2017 [36] Thailand
Randomized
controlled trial
15 CP children
(I–III GMFCS)
Age: 7–16 years
8 weeks
3 times/week
70 min/session
Intervention group (n = 8):
Functional strength
training/conventional therapy
Control group (n = 7):
Conventional therapy
TUG:
Intervention group (p = 0.734):
Pre: 10.1 ± 3.1
Post: 9.5 ± 3.9
Control group (p = 0.953):
Pre: 11.6 ± 3
Post: 11.7 ± 3.4
Gait speed (cm/s):
Intervention group (p = 0.280):
Pre: 100 ± 20
Post: 111 ± 20
Control group:
Pre: 111 ± 20
Post: 99 ± 20
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Salem et al., 2009
[32] USA
Randomized
controlled trial
10 CP children
(I–III GMFCS)
Average age:
8 years
5 weeks
2 times/week
Intervention group (n = 5):
Functional strength training
Control group (n = 5):
Conventional therapy
GMFM D: Intervention group
(p = 0.484): Pre: 62.02 ± 25.24
Post: 73.3 ± 25.04
Control group (p = 0.753):
Pre: 64.6 ± 26.07
Post: 69.7 ± 24.97
GMFM E: Intervention group
(p = 0.654): Pre: 45.62 ± 31.57
Post: 54.66 ± 31.9
Control group (p = 0.810):
Pre: 49.42 ± 25.42
Post: 53.3 ± 25.62
TUG:
Intervention group (p = 0.571):
Pre: 19.8 ± 11.32
Post: 15.8 ± 10.83
Control group (p = 0.830):
Pre: 23.6 ± 13.09
Post: 11.7 ± 3.4
Scholtes et al., 2010
[13]
The
Netherlands
Randomized
controlled trial
51 CP children
(I–III GMFCS)
Age:6–13 years
12 weeks
3 times/week
60 min/session
Intervention group (n = 26):
Functional strength training
Control group (n = 25):
Conventional therapy
GMFM:
Intervention group (p = 1.000):
Pre: 76.1 ± 12.8
Post: 76.1 ± 11.8
Control group (p = 0.721):
Pre: 71.8 ± 12.5
Post: 73.1 ± 12.4 Lateral step up:
Intervention group (p = 0.299):
Pre: 15.6 ± 4
Post: 17 ± 5.1
Control group (p = 0.144):
Pre: 13.3 ± 5.4
Post: 15.4 ± 4.3
MobQue:
Intervention group (p = 0.894):
Pre: 68.42 ± 20.93
Post: 67.51 ± 24.5
Control group (p = 0.831):
Pre: 64.77 ± 26.26
Post: 66.4 ± 25.93
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Tedla et al., 2014
[33] Saudi Arabia
Randomized
controlled trial
60 CP children
(I–V GMFCS)
Age: 5–14 years
6 weeks
3 times/week
60–90 min/session
Intervention group (n = 30):
Progressive strength training.
Control group (n = 30):
Conventional therapy
GMFM (p < 0.001):
Intervention group:
Pre: 69.02 ± 7.64
Post: 78.84 ± 6.45
Unnithan et al.,
2007 [34]
United
Kingdom and
Greece
Randomized
controlled trial
13 CP children
(II–III GMFCS)
Age:14–18 years
12 weeks
3 times/week
70 min/session
Intervention group (n = 7):
Progressive strength
training/conventional
neurodevelopmental therapy
Control group (n = 6):
Conventional
neurodevelopmental therapy
GMFM: Intervention group
(p = 0.708): Pre: 30.35 ± 16.95
Post: 33.85 ± 17.87
Control group (p = 1.000):
Pre: 30.76 ± 12.52
Post: 30.76 ± 12.52
a Cerebral palsy; b Gross Motor Function Classification System; c Gross Motor Function Measure; d Time Up and Go; e Mobility Questionnaire. USA—United States of America.
Table 3. Results of the quality assessment based on the Physiotherapy Evidence Database (PEDro) Scale, for the studies finally included.
Criteria
Aye Dodd Engsberg Fowler Jung Lee Lee Lee Pandey Peungsuwan Liao Salem Scholtes Tedla Unnithan
2016 2003 2006 2010 2013 2008 2014 2015 2011 2017 2007 2009 2010 2014 2007
Eligibility criteria were specified a 1 1 1 1 0 1 1 0 1 1 1 0 1 1 1
Random allocation n.a. b 1 1 1 n.a. 1 n.a. 1 1 1 1 1 1 1 1
Cancelled allocation n.a. 1 0 0 n.a. 1 n.a. 0 1 1 0 1 1 0 0
Groups similar at baseline n.a. 0 0 1 n.a. 0 n.a. 0 0 1 0 0 0 0 1
Subject blinding n.a. 0 0 0 n.a. 0 n.a. 0 0 0 0 0 0 0 0
Therapist blinding n.a. 0 0 0 n.a. 0 n.a. 0 0 0 0 0 0 0 0
Assessor blinding n.a. 1 0 1 n.a. 0 n.a. 1 1 1 1 1 1 0 0
<15% dropout 0 1 0 1 1 1 0 1 1 1 0 1 1 1 1
Intention-to-treat analysis n.a. 0 0 0 n.a. 1 n.a. 1 0 1 0 1 0 0 1
Between-group statistical comparisons 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Point measures and variability data 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Total score (0/10) 2 6 3 6 3 6 2 6 6 8 4 7 6 4 6
a Criterium that does not contribute to the total score because it evaluates the external validity of the study; b n.a. = not applicable (non-controlled studies, only intervention group).
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3.1. Intra-Group Pre–Post Difference in the Intervention Group
Fifteen studies [8–10,12–14,31–39] provided data related to a resistance therapy intervention that
could be meta-analyzed for the evaluation of the pre–post intra-group difference in the motor function.
These 15 studies used up to four different scales (GMFM, MobQue, LSU, and TUG). Twelve of these
studies provided data on the GMFM scale, three of these studies provided data on the TUG and LSU
scales, and two studies provided data on the MobQue scale.
Figure 2 shows the standardized mean difference (SMD) in a basic subgroup analysis according to
the scale used in the study.
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Figure 2. Pre–post intra-group difference in the intervention group with resistance therapy:
all measurements and follow-ups.
The individual results of the studies presented a moderate heterogeneity between them (Q = 79.64,
degrees of freedom (df) = 32, p < 0.001, I2 = 59.82%, Tau = 0.46) (see Table 4). The overall effect was in
favor of the intervention, reaching statistical significance both in the fixed-effects model (SMD = 0.42,
95% CI = 0.30 to 0.55, p < 0.001) and in the random-effects model (SMD = 0.37, 95% CI = 0.21 to 0.52,
p < 0.001) (see Figure 2).
Table 4. Global heterogeneity in the intervention group: all scales and follow-ups.
Heterogeneity
df p (χ2) I2 (%) τ2 τ
All scales and all follow-ups 33 79.64 32 0.000 59.82 0.21 0.46
GMFM A 18 19.00 17 0.328 10.54 0.02 0.13
LSU B 9 51.64 8 0.000 84.51 1.00 1.00
MobQue C 3 0.78 2 0.676 0.00 0.00 0.00
TUG D 3 0.24 2 0.888 0.00 0.00 0.00
A Gross Motor Function Measure; B Lateral Step Up; C Mobility Questionnaire; D Time Up and Go. df—degrees
of freedom.
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Determinations were also restricted to the longer and shorter follow-ups for each article. No large
differences were observed, with statistically significant SMDs of 0.38 (95% CI = 0.20 to 0.55) by
restricting the determinations to the shorter follow-up, and 0.41 (95% CI = 0.24 to 0.59) by restricting
the determinations to the longer follow-up under the random-effects model (data not shown in figures
or tables).
Attending to the duration of the complete therapy, results showed a larger effect with an SMD of
0.75 (95% CI = 0.41 to 1.08), when the duration of the complete therapy was less than or equal to six weeks,
and a smaller effect with an SMD of 0.18 (95% CI = −0.002 to 0.37), in studies with a longer duration of
the complete therapy (from 7–12 weeks) (see Figure S1 and Table S1, Supplementary Materials).
Regarding the number of sessions, the results showed a difference in favor of studies with sessions
applied fewer than three days a week with an SMD of 1.59 (95% CI = 0.67 to 2.50), compared to studies
with sessions applied three days a week with an SMD of 0.32 (95% CI = 0.19 to 0.46) (see Figure S2 and
Table S2, Supplementary Materials).
In relation to the duration of each session, studies showed a larger effect when the duration of the
session was less than 30 min with an SMD of 1.08 (95% CI = 0.52 to 1.64) compared to studies that
used between 30 and 60 min for each session with an SMD of 0.20 (95% CI = 0.03 to 0.38) or those that
used between 60 and 90 min with an SMD of 0.57 (95% CI = −0.13 to 1.28) (see Figure S3 and Table S3,
Supplementary Materials).
Regarding the protocol used, in seven studies, a “progressive strength training” protocol was
used [9,13,14,33,34,37,39]. In three of the studies, the protocol used was a “table of resistance
exercises” [10,12,38]. In four of the studies, the protocol used for resistance therapy was “functional
training” [8,32,35,36], and, in one study, the protocol used for resistance therapy was a static bicycle [31].
The subgroup analysis showed a larger effect when using the “functional exercises” protocol with an
SMD of 1.25 (95% CI = 0.46 to 2.04) (see Figure S4 and Table S4, Supplementary Materials).
Attending the methodological quality, the effect was in favor of intervention both in studies with
an “excellent” score (SMD = 0.30, 95% CI = −0.29 to 0.88) or a “good” overall score (SMD = 0.55, 95%
CI = 0.24 to 0.85) and in studies with a “fair” score (SMD = 0.47, 95% CI = −0.15 to 1.10) or “poor”
score (SMD = 0.51, 95% CI = 0.22 to 0.80) (see Figure S5 and Table S5, Supplementary Materials).
3.2. Intra-Group Difference in the Control Group
Figure 3 shows the SMD in the control group, relative to the 10 controlled clinical trials [8,10,12–
14,31,32,34–36].
The studies showed no heterogeneity between them (Q = 9.23, df = 25, p = 0.998, I2 = 0%, Tau= 0)
(see Table 5). The overall effect was in favor of the intervention, although only slightly and without
reaching statistical significance using the fixed-effects model (SMD = 0.10, 95% CI = −0.05 to 0.26,
p = 0.178) (see Figure 3).
Figure S6 and Table S6 (Supplementary Materials) present a subgroup analysis according to the
therapy used in the control group. When no therapy was used for the control group, the intra-group
difference was against with an SMD of −0.15. In contrast, studies in which the control group received
therapy were in favor with an overall SMD of 0.16.
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Table 5. Global heterogeneity in the control group: all scales and follow-ups.
Scales N of Determinations
Heterogeneity
Q df p (χ2) I2 (%) τ2 τ
All scales and all follow-ups 26 9.23 25 0.998 0.00 0.00 0.00
GMFM A 12 0.42 11 1.000 0.00 0.00 0.00
LSU B 9 8.69 8 0.369 7.97 0.01 0.12
MobQue C 3 0.02 2 0.990 0.00 0.00 0.00
TUG D 2 0.04 1 0.840 0.00 0.00 0.00
A Gross Motor Function Measure; B Lateral Step Up; C Mobility Questionnaire; D Time Up and Go.
3.3. Between-Group Difference
Eight studies [8,10,12–14,31–34] provided data related to a resistance therapy intervention that
could be meta-analyzed for the evaluation of the between-group difference, i.e., between the intervention
and control group, using the “GMFM” scale.
Heterogeneity was high (Q = 2720.45, df = 11, p = 0, I2 = 99.60%, Tau = 1.60). The overall effect
was in favor of intervention, reaching statistical significance using the fixed-effects model (MD = 0.34,
95% CI = 0.28 to 0.39, p < 0.001) and the random-effects model (MD = 1.73, 95% CI = 0.81 to 2.64,
p < 0.001) (see Figure 4 and Table 6).
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Table 6. Global heterogeneity between groups on the GMFM scale: all follow-ups.
Difference between Groups
Using GMFM A N of Determinations
Heterogeneity
Q df P (χ2) I2 (%) τ2 τ
All follow-ups 12 2720.45 11 0 99.60 2.56 1.60
A Gross Motor Function Measure.
3.4. Publication Bias
In terms of publication bias in relation to the intra-group difference, the funnel plot was barely
asymmetric. When incorporating the Duval and Tweedie “trim and fill” procedure, the model did not
include any study; therefore, the overall effect adjusted by this procedure was similar to that observed
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Figure 6. Funnel plot diagram of the standard error (y-axis) and the SMD (x-axis), after incorporating
the Duval and Tweedie “trim and fill” procedure: pre–post intra-group difference in the intervention
group with resistance therapy in all follow-ups.
Regarding the difference in GMFM scale between groups, the funnel plot visually presented
an asymmetry with a larger number of studies to the right (in favor of resistance therapy).
When incorporating the Duval and Tweedie “trim and fill” procedure, the model included six
studies from the left (represented as black circles). The best adjusted (unbiased) estimate using this
procedure was, therefore, against intervention with an adjusted overall MD of −0.21 and −0.13 using
the fixed-effects and random-effects models, respectively (see Figures 7 and 8).Int. J. Environ. Res. Public Health 2019, 16, x 23 of 27 
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the Duval and Tweedie “trim and fill” procedure: difference between groups in the intervention group
with resistance therapy on the GMFM scale in all follow-ups.
4. Discussion
In relation to the intra-group pre–post difference in motor function in the group intervened
with resistance therapy, according to the criteria of Cohen et al. (1988) [40], the overall effect of the
intervention would be small with an SMD of 0.37 under the random-effects model. The results support
the absence of a publication bias in terms of intra-group results [26,27]. The result would be more
favorable than that shown by Ryan et al. in their review published in 2017 [7], which reported a
non-significant SMD of 0.12 (95% CI = −0.19 to 0.43), based on seven primary studies that included a
total of 164 children and adolescents.
Three out of the 15 studies were non-controlled one-arm clinical trials. By restricting the study to
the 12 controlled clinical trials (with two arms), the overall effect size of the intervention was superior,
with an SMD of 0.50 (random effects).
One study stood out for its positive impact on the LSU scale in terms of results and
heterogeneity [35]. This study provided determinations at four weeks and at a follow-up of unspecified
duration. In this study, the control group did not receive any intervention. This may be the explanation
for these favorable results, since there was also another study where the control group did not receive
any therapy [31], and the results stood out positively as well.
Another study [33] stood out for its positive result and its impact on heterogeneity on the GMFM
scale. This is the only study in which children with greater motor impairment (levels I–V GMFCS
(Gross Motor Function Classification System)) were considered among its inclusion criteria. This would
explain its different results, more in favor than the rest of the studies.
Fifteen studies reported results on more than one scale. The results more favorable to the
intervention were related to the LSU scale. The three studies that used this scale provided up to nine
determinations on this scale, with an SMD of 1.33 [12,13,35]. It must be taken into account that the
study with the most favorable results for the intervention [35], with an SMD of 3.56 in the longest
follow-up, contributed with up to four determinations to the meta-analysis. It, therefore, had a greater
positive influence on the overall effect.
Twelve of the 15 studies used the GMFM scale [8–10,12–14,31–34,37,39], making it the most used
scale. Our results showed a statistically significant effect size of 0.37 in this scale, similar to the SMD of
0.38 reported in the review by Ryan et al. in 2017 [7].
The TUG scale was used in three out of the 15 studies [32,36,38], showing an SMD of 0.36.
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The MobQue scale was the scale for which the effect size was the lowest (SMD = 0.10). Nevertheless,
it was only used in two studies [13,14].
The GMFM scale and MobQue questionnaire show the score as a percentage, both measuring
the motor function through a series of functional activities. The GMFM uses five dimensions, and the
MobQue is a questionnaire of daily life activities of children with CP that is completed by their parents.
The LSU and TUG tests evaluate more concrete activities; the former measures the full number of
repetitions (upward and downward foot full movement) in which the child can participate on a step,
and the latter measures the time it takes a person to get out of a chair, walk three meters, turn around,
return to the chair, and sit.
With respect to the control group, the intra-group increase in motor function was lower
(SMD = 0.10) (fixed effects) and did not reach statistical significance. There was no heterogeneity
between the results in the studies. In eight of the 10 controlled studies, the control group received
conventional therapy based on neurodevelopmental therapy, which included muscle stretching,
functional exercises, and re-education of movement and gait. In two studies [31,35], no therapy was
used for the control group. In these two studies, the intragroup difference was against with an SMD of
−0.15, compared to the studies in which the control group received therapy, which showed an overall
SMD in favor of 0.16.
Regarding the scales used, comparing the intra-group pre–post difference in the control group
with the result discussed above in relation to the intervention group, we found the greatest differences
in favor of the intervention group for the LSU scale, because the SMD was only 0.08 in the control
group for this scale, followed by the GMFM scale (SMD = 0.12 in the control group) and the TUG scale
(SMD = 0.04 in the control group). With respect to the MobQue scale, the results were similar in both
groups (with similar SMDs of 0.10 in both control and intervention groups).
In relation to subgroup analysis based on the predefined sources of heterogeneity, the lower
number of studies when forming the subgroups highlighted the individual influence of studies with
more favorable results, such as the study by Pandey et al. [35], which used a 60-min “functional
exercises” protocol, two days per week, with determinations at four weeks.
In any case, this analysis supports that a duration of six weeks or even less is enough to show a
positive effect of the intervention, and that a longer duration (between seven and 12 weeks) does not
appear to have a larger impact. Regarding the number of sessions, the difference between two and
three sessions per week does not seem to have much clinical impact, if we disregard the influence of the
study cited above [35]. In relation to the duration of each session, the results showed a smaller effect
for longer training sessions (longer than 30 min); thus, fatigue would have to be taken into account.
In this sense, a duration of each session of less than 30 min would lead to less fatigue, which seems to
be associated with a larger effect of the intervention. The subgroup analysis shows a greater effect
when using the “functional exercises” protocol, influenced once again by the favorable results of the
study published by Pandey et al. (2011) [35].
These results do not coincide with the recommendations of the National Strength Training and
Fitness Association (NSCA), which recommends, in healthy children, a training including 5–10 min of
exercises using 50–85% of maximum resistance, 2–4 times per week for periods of 8–20 weeks [41].
None of the studies followed all NSCA recommendations. However, the response to training in
children with CP is presumably quite different from the healthy population, and the adaptability of
neural factors after resistance training may be reduced in these children [42]. Our results are similar to
the results of the meta-analysis by Park et al., published in 2014 [6], which recommended interventions
of 6–8 weeks of duration, with a frequency of 2–3 days per week; however, in our case, a slightly
shorter duration (less than 30 min would be sufficient) is recommended rather than the 40–50 min in
their meta-analysis. One of the limitations of resistance therapy is that long training programs can lead
to demotivation at an early age, resulting in abandonment. It is, therefore, necessary to review and
modify the games and exercises used to perform the resistance therapy, so as to guarantee adherence.
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Depending on the methodological quality, the effect was in favor of intervention both in studies
rated as “excellent” (n = 2) [32,36] or “good” (n = 7) [8,12–14,31,34,35] and in studies rated as “fair”
(n = 6) [9,10,33,39] or “poor” (n = 2) [37,38], with no group scoring above an SMD of 0.5 (cut-off point
considered for a moderate effect according to Cohen criteria).
Regarding the between-group difference in relation to the comparison of the GMFM scale, the mean
differences (MDs) and their corresponding 95% CIs were shown under the random-effects model due
to the high heterogeneity of the results (I2 > 99%). The possibility of obtaining the effect size on the
natural scale allowed the results to be interpreted in non-standardized units of measurement.
In terms of the between-group difference, results restricted to the GMFM scale would support a
positive difference in favor of resistance therapy with a mean difference of 1.73 points out of 100 (%).
That is, despite the fact that children with cerebral palsy always achieve an increase in their motor
function (determined through the GMFM scale), on average, the group intervened with resistance
therapy obtained an increase of 1.73 points out of 100 on the GMFM scale with respect to the control
group. This result is slightly lower than the two-point increase over 100 (95% CI = 0% to 4%) based on
four studies (n = 99) [8,10,43,44] obtained in the meta-analysis published by Scianni et al., in 2009 [5].
The marked asymmetry of the funnel plot in the analysis supports the existence of a publication
bias regarding the between-group difference, with controlled studies with more favorable results
published more frequently. In this context, if we take into account the six studies from the left included
when incorporating the Duval and Tweedle “trim and fill” procedure, the best adjusted (unbiased)
estimate would actually be against intervention. This supports the need to register all clinical trials and
the publication of all research protocols, along with the awareness-raising work of journal editors to
ensure publication of results, either in favor or against the hypothesis. New studies must also consider
the clinical relevance of the findings, from the points of view of both superiority and non-inferiority.
In addition to the possibility of publication bias, another limitation of the present meta-analysis would
be the low quality of some primary studies, and the small sample size of most of them.
5. Conclusions
In conclusion, our meta-analysis showed a statistically significant positive effect on motor function
in favor of the use of resistance therapy in weakened musculature in children with CP. Resistance
therapy would not only increase the strength of the musculature of children with CP, but this increased
strength would also have an impact on the motor function. Nevertheless, it is possible that the
between-group effect may have been overestimated due to the existence of a publication bias. All future
randomized controlled clinical trials should be registered and published to address this issue. Future
studies should also analyze the clinical relevance of the results, examining the most optimal regimens
in terms of duration of therapy, number of sessions, duration of each session, and type of intervention
protocol used.
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